表紙
市場調查報告書

分子診斷的市場規模,佔有率,及趨勢分析報告:各技術,各檢驗地方,各產品(測量器,試劑),各用途(腫瘤學,感染疾病) 市場區隔預測 2019年 - 2026年

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology, By Application, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 355233
出版日期 內容資訊 英文 185 Pages
商品交期: 2-3個工作天內
價格
分子診斷的市場規模,佔有率,及趨勢分析報告:各技術,各檢驗地方,各產品(測量器,試劑),各用途(腫瘤學,感染疾病) 市場區隔預測 2019年 - 2026年 Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology, By Application, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月12日內容資訊: 英文 185 Pages
簡介

全球分子診斷市場,預計從2019年到2026年之間以9.1%的年複合成長率成長,2026年達到198億美元。人類乳突病毒和流感等的感染疾病的罹患率增加,是帶動市場的主要原因。

本報告提供全球分子診斷市場的相關調查,市場趨勢和預測,各產品、檢驗地方、技術、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查方法及範圍

  • 市場區隔及範圍
  • 市場定義
  • 資訊採購
  • 資訊分析
  • 市場形成及資料的視覺化
  • 資料檢驗及公開

第2章 摘要整理

  • 市場預測
  • 各市場區隔預測
  • 競爭的洞察

第3章 分子診斷的市場變動,趨勢及範圍

  • 分子診斷市場譜系預測
  • 滲透及成長預測的製圖
  • 法律規範
  • 市場動態
  • 分子診斷市場分析工具

第4章 分子診斷市場 - 競爭分析

  • 主要各打入市場業者,最近的趨勢及影響分析
  • 公司/競爭的分類(主要創新者,市場領導者,新興企業)
  • 進貨處的展望
  • 公開公司
  • 民營企業

第5章 分子診斷市場:各產品的概算及趨勢分析

  • 定義及範圍
  • 市場佔有率分析 2018年及2026年
  • 分子診斷市場 2014年∼2026年
  • 市場規模及預測及趨勢分析 2014年∼2026年
    • 設備
    • 試劑
    • 其他

第6章 分子診斷市場:各檢驗地方的概算及趨勢分析

  • 定義及範圍
  • 市場佔有率分析 2018年及2026年
  • 分子診斷市場 2014年∼2026年
  • 市場規模及預測及趨勢分析 2014年∼2026年
    • 治療現場
    • 自我檢測或OTC
    • 中央研究所

第7章 分子診斷市場:各技術的概算及趨勢分析

  • 定義及範圍
  • 市場佔有率分析 2018年及2026年
  • 分子診斷市場 2014年∼2026年
  • 市場規模及預測及趨勢分析 2014年∼2026年
    • PCR
    • ISH
    • INAAT
    • 晶片及微陣列
    • 質譜分析
    • 序列
    • TMA
    • 其他
  • 技術市場
    • PCR
    • ISH
    • INAAT
    • 晶片及微陣列
    • 質譜分析
    • 序列
    • TMA
    • 其他

第8章 分子診斷市場:各用途的概算及趨勢分析

  • 定義及範圍
  • 市場佔有率分析 2018年及2026年
  • 分子診斷市場 2014年∼2026年
  • 市場規模及預測及趨勢分析 2014年∼2026年
    • 腫瘤學
    • 藥理基因學
    • 感染疾病
    • 遺傳基因檢驗
    • 神經疾病
    • 循環系統疾病
    • 微生物學
    • 其他

第9章 分子診斷市場:各地區的概算及趨勢分析,各產品、檢驗地方、技術、用途

  • 分子診斷市場:地區趨勢分析 2018年及2026年
  • 分子診斷市場:主要企業 2018年
  • 各要因SWOT分析(政治,法,經濟,技術)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東及非洲地區

第10章 競爭環境

  • Strategy Framework
  • Heat Map Analysis of Private Companies
  • Abbott
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Dako
  • Danaher Corporation
  • Hologic, Inc. (Gen Probe)
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc
  • Novartis (Grifols)
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare Private Limited
  • Sysmex Corporation

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-086-6

The global molecular diagnostics market size is expected to reach USD 18.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 9.0% over the forecast period. Increasing prevalence of infectious diseases such as influenza and human papillomavirus is projected to be the key factor the growth of the market.

In the underdeveloped regions of Africa, increasing instances of infections such as tuberculosis and HIV have been witnessed in the last few years. This is projected to drive the demand for accurate and early diagnostic techniques to curb the spread of these infections.

Rapid technological advancements-leading to accurate results, portability, and cost-effectiveness-are expected to be a high impact rendering driver for this market. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Companies such as Sigma Aldrich Corporation and Qiagen are developing a new range of molecular diagnostic techniques, such as Transcription-Mediated Amplification (TMA) and Loop-Mediated Isothermal Amplification (LAMP), for the diagnosis of tumors.

Key players in the market are adopting various marketing strategies such as collaborations with technologically advanced companies and diagnostic centers. Furthermore, players are focusing on expanding their geographic presence in order to increase their market share.

Further key findings from the report suggest:

  • Reagents dominated the market in 2019 and is also projected to be the fastest-growing product segment owing to its high adoption in research and clinical settings. Standard reagents also provide efficient and accurate results
  • Instruments such as next generation sequencing platforms and PCR are increasingly preferred by diagnostic institutes and central laboratories as these tests deliver reliable and quick results and are suitable for a number of diagnostic procedures
  • Central laboratories emerged as the leading test location for molecular diagnostics in 2019. This is attributed to the availability of skilled labor and well-established infrastructure
  • Point-of-care is expected to be the fastest-growing segment over the forecast period owing to increase in demand for bedside testing, accuracy of results, and rise in healthcare awareness
  • Infectious diseases were the largest revenue generating segment in 2019 as molecular diagnostics offer clinicians with better substitutes to diagnose numerous infectious pathogens, bacteria, and virus in a short time while producing extremely accurate results
  • The oncology segment is projected to exhibit a CAGR of around 11.3% over the forecast period owing to increasing awareness amongst patients and healthcare professionals regarding available technologies such as molecular testing for cancer diagnosis
  • On the basis of technology, PCR was the largest revenue generating segment in 2019 owing to factors such as growing applications of multiplex PCR and commercialization of easy-to-use PCR-based molecular diagnostic kits
  • North America was the largest revenue generating region in 2019, followed by Europe. Key factors attributing to their dominance are high patient awareness levels, sophisticated healthcare infrastructure, growing healthcare expenditure, and high R&D pertaining to drug discovery and development

Some of the major players operating in molecular diagnostics market are F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Novartis AG (Grifols); Danaher Corporation; Alere, Inc.; Sysmex Corporation; bioMerieux SA; Becton, Dickinson and Company; Hologic, Inc. (Gen Probe); Johnson & Johnson Services, Inc.; Bayer AG; Cepheid; Dako; and Qiagen.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
  • 1.2 Research Methodology
  • 1.3 Research Assumptions
    • 1.3.1 Estimates and Forecast Timeline
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country wise market estimation using bottom up approach
  • 1.9 Global Market: CAGR Calculation
  • 1.10 List of Secondary Sources
  • 1.11 List of Primary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1:
    • 1.12.2 Objective 2:
  • 1.13 List of Tables

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Molecular Diagnostics Market Variables, Trends & Scope

  • 3.1 Molecular Diagnostics Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory and Reimbursement Framework
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Increase in geriatric population
      • 3.4.1.2 Introduction of technologically advanced products
      • 3.4.1.3 Increase in demand for point-of-care facilities
      • 3.4.1.4 Growing prevalence of target diseases
      • 3.4.1.5 Increasing external funding for R&D
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Presence of ambiguous regulatory framework
      • 3.4.2.2 High prices of molecular diagnostics tests
  • 3.5 Molecular Diagnostics Market Analysis Tools
    • 3.5.1 Porter's Five Forces Analysis
    • 3.5.2 SWOT Analysis, By factor (Political & Legal, Economic and Technological)
    • 3.5.3 Major deals & strategic alliances analysis
      • 3.5.3.1 New product launch
      • 3.5.3.2 Mergers and acquisitions
      • 3.5.3.3 Expansion
      • 3.5.3.4 Partnerships
      • 3.5.3.5 Marketing & promotions
      • 3.5.3.6 Market entry strategies

Chapter 4 Molecular Diagnostics Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
    • 4.1.2 Innovators
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive Dashboard Analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies /technology disruptors/innovators
    • 4.4.2 Regional network map

Chapter 5 Products Business Analysis

  • 5.1 Molecular diagnostics market: Products Movement Analysis
  • 5.2 Instruments
    • 5.2.1 Instruments market estimates and forecast, 2016 - 2027
  • 5.3 Reagents
    • 5.3.1 Reagents market estimates and forecast, 2016 - 2027
  • 5.4 Others
    • 5.4.1 Others market estimates and forecast, 2016 - 2027

Chapter 6 Test Location Business Analysis

  • 6.1 Molecular diagnostics market: Test Location Movement Analysis
  • 6.2 Point of Care (PoC)
    • 6.2.1 PoC market estimates and forecast, 2016 - 2027
  • 6.3 Self-testing or OTC
    • 6.3.1 Self-testing or OTC market estimates and forecast, 2016 - 2027
  • 6.4 Central Laboratories
    • 6.4.1 Central Laboratories market estimates and forecast, 2016 - 2027

Chapter 7 Technology Business Analysis

  • 7.1 Molecular diagnostics market: Technology Movement Analysis
  • 7.2 Polymerase Chain Reaction
    • 7.2.1 Polymerase Chain Reaction market estimates and forecast, 2016 - 2027
    • 7.2.2 PCR market, by Type
      • 7.2.2.1 Multiplex PCR
      • 7.2.2.1.1 Multiplex PCR market estimates and forecast, 2016 - 2027
      • 7.2.2.2 Other PCR
      • 7.2.2.2.1 Other PCR market estimates and forecast, 2016 - 2027
    • 7.2.3 PCR market, by Product
      • 7.2.3.1 Instruments
      • 7.2.3.1.1 Instruments market for PCR estimates and forecast, 2016 - 2027
      • 7.2.3.2 Reagents
      • 7.2.3.2.1 Reagents market for PCR estimates and forecast, 2016 - 2027
      • 7.2.3.3 Others
      • 7.2.3.3.1 Others market for PCR estimates and forecast, 2016 - 2027
  • 7.3 In Situ Hybridization (ISH)
    • 7.3.1 In Situ Hybridization market estimates and forecast, 2016 - 2027
    • 7.3.2 Instruments
      • 7.3.2.1 Instruments market for ISH estimates and forecast, 2016 - 2027
    • 7.3.3 Reagents
      • 7.3.3.1 Reagents market for ISH estimates and forecast, 2016 - 2027
    • 7.3.4 Others
      • 7.3.4.1 Others market for ISH estimates and forecast, 2016 - 2027
  • 7.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.4.1 INAAT market estimates and forecast, 2016 - 2027
    • 7.4.2 Instruments
      • 7.4.2.1 Instruments market for INAAT estimates and forecast, 2016 - 2027
    • 7.4.3 Reagents
      • 7.4.3.1 Reagents market for INAAT estimates and forecast, 2016 - 2027
    • 7.4.4 Others
      • 7.4.4.1 Others market for INAAT estimates and forecast, 2016 - 2027
  • 7.5 Chips and Microarrays
    • 7.5.1 Chips and Microarrays market estimates and forecast, 2016 - 2027
    • 7.5.2 Instruments
      • 7.5.2.1 Instruments market for Chips and microarrays estimates and forecast, 2016 - 2027
    • 7.5.3 Reagents
      • 7.5.3.1 Reagents market for Chips and microarrays estimates and forecast, 2016 - 2027
    • 7.5.4 Others
      • 7.5.4.1 Others market for Chips and microarrays estimates and forecast, 2016 - 2027
  • 7.6 Mass Spectrometry
    • 7.6.1 Mass Spectrometry market estimates and forecast, 2016 - 2027
    • 7.6.2 Instruments
      • 7.6.2.1 Instruments market for Mass spectrometry estimates and forecast, 2016 - 2027
    • 7.6.3 Reagents
      • 7.6.3.1 Reagents market for mass spectrometry estimates and forecast, 2016 - 2027
    • 7.6.4 Others
      • 7.6.4.1 Others market for mass spectrometry estimates and forecast, 2016 - 2027
  • 7.7 Sequencing
    • 7.7.1 Sequencing market estimates and forecast, 2016 - 2027
    • 7.7.2 Instruments
      • 7.7.2.1 Instruments market for Sequencing estimates and forecast, 2016 - 2027
    • 7.7.3 Reagents
      • 7.7.3.1 Reagents market for sequencing estimates and forecast, 2016 - 2027
    • 7.7.4 Others
      • 7.7.4.1 Others market for sequencing estimates and forecast, 2016 - 2027
  • 7.8 Transcription Mediated Amplification (TMA)
    • 7.8.1 TMA market estimates and forecast, 2016 - 2027
    • 7.8.2 Instruments
      • 7.8.2.1 Instruments market for TMA estimates and forecast, 2016 - 2027
    • 7.8.3 Reagents
      • 7.8.3.1 Reagents market for TMA estimates and forecast, 2016 - 2027
    • 7.8.4 Others
      • 7.8.4.1 Others market for TMA estimates and forecast, 2016 - 2027
  • 7.9 Others
    • 7.9.1 Others market estimates and forecast, 2016 - 2027
    • 7.9.2 Instruments
      • 7.9.2.1 Instruments market for Others estimates and forecast, 2016 - 2027
    • 7.9.3 Reagents
      • 7.9.3.1 Reagents market for others estimates and forecast, 2016 - 2027
    • 7.9.4 Others
      • 7.9.4.1 Others market for Others estimates and forecast, 2016 - 2027

Chapter 8 Application Business Analysis

  • 8.1 Molecular diagnostics market: Application Movement Analysis
  • 8.2 Oncology
    • 8.2.1 Oncology market estimates and forecast, 2016 - 2027
    • 8.2.2 Breast cancer
      • 8.2.2.1 Breast cancer market estimates and forecast, 2016 - 2027
    • 8.2.3 Prostate cancer
      • 8.2.3.1 Prostate cancer market estimates and forecast, 2016 - 2027
    • 8.2.4 Colorectal cancer
      • 8.2.4.1 Colorectal cancer market estimates and forecast, 2016 - 2027
    • 8.2.5 Cervical cancer
      • 8.2.5.1 Cervical cancer market estimates and forecast, 2016 - 2027
    • 8.2.6 Kidney cancer
      • 8.2.6.1 Kidney cancer market estimates and forecast, 2016 - 2027
    • 8.2.7 Liver cancer
      • 8.2.7.1 Liver cancer market estimates and forecast, 2016 - 2027
    • 8.2.8 Blood cancer
      • 8.2.8.1 Blood cancer market estimates and forecast, 2016 - 2027
    • 8.2.9 Lung cancer
      • 8.2.9.1 Lung cancer market estimates and forecast, 2016 - 2027
    • 8.2.10 Other cancers
      • 8.2.10.1 Other cancer market estimates and forecast, 2016 - 2027
  • 8.3 Pharmacogenomics
    • 8.3.1 Pharmacogenomics Market estimates and forecast, 2016 - 2027
  • 8.4 Infectious Diseases
    • 8.4.1 Infectious Diseases market estimates and forecast, 2016 - 2027
    • 8.4.2 Methicillin-resistant Staphylococcus Aureus (MRSA)
      • 8.4.2.1 MRSA market estimates and forecast, 2016 - 2027
    • 8.4.3 Clostridium difficile
      • 8.4.3.1 Clostridium difficile market estimates and forecast, 2016 - 2027
    • 8.4.4 Vancomycin-Resistant Enterococci (VRE)
      • 8.4.4.1 VRE market estimates and forecast, 2016 - 2027
    • 8.4.5 Carbapenem-resistant bacteria
      • 8.4.5.1 Carbapenem-resistant bacteria market estimates and forecast, 2016 - 2027
    • 8.4.6 Flu
      • 8.4.6.1 Flu market estimates and forecast, 2016 - 2027
    • 8.4.7 Respiratory Syncytial Virus (RSV)
      • 8.4.7.1 RSV market estimates and forecast, 2016 - 2027
    • 8.4.8 Candida
      • 8.4.8.1 Candida market estimates and forecast, 2016 - 2027
    • 8.4.9 Tuberculosis (TB) and drug-resistant TBA
      • 8.4.9.1 TB and drug-resistant TB market estimates and forecast, 2016 - 2027
    • 8.4.10 Meningitis
      • 8.4.10.1 Meningitis market estimates and forecast, 2016 - 2027
    • 8.4.11 Gastrointestinal panel testing
      • 8.4.11.1 Gastrointestinal panel testing market estimates and forecast, 2016 - 2027
    • 8.4.12 Chlamydia
      • 8.4.12.1 Chlamydia market estimates and forecast, 2016 - 2027
    • 8.4.13 Gonorrhea
      • 8.4.13.1 Gonorrhea market estimates and forecast, 2016 - 2027
    • 8.4.14 HIV
      • 8.4.14.1 HIV market estimates and forecast, 2016 - 2027
    • 8.4.15 Hepatitis C
      • 8.4.15.1 Hepatitis C market estimates and forecast, 2016 - 2027
    • 8.4.16 Hepatitis B
      • 8.4.16.1 Hepatitis B market estimates and forecast, 2016 - 2027
    • 8.4.17 Other infectious disease market
      • 8.4.17.1 Other infectious disease market estimates and forecast, 2016 - 2027
  • 8.5 Genetic Testing
    • 8.5.1 Genetic Testing Market estimates and forecast, 2016 - 2027
    • 8.5.2 Newborn screening
      • 8.5.2.1 Newborn screening market estimates and forecast, 2016 - 2027
    • 8.5.3 Predictive and Presymptomatic testing
      • 8.5.3.1 Predictive and Presymptomatic testing market estimates and forecast, 2016 - 2027
    • 8.5.4 Other genetic testing
      • 8.5.4.1 Other genetic testing market estimates and forecast, 2016 - 2027
  • 8.6 Neurological Diseases
    • 8.6.1 Neurological Diseases Market estimates and forecast, 2016 - 2027
  • 8.7 Cardiovascular Diseases
    • 8.7.1 Cardiovascular Diseases Market estimates and forecast, 2016 - 2027
  • 8.8 Microbiology
    • 8.8.1 Microbiology Market estimates and forecast, 2016 - 2027
  • 8.9 Others
    • 8.9.1 Others Market estimates and forecast, 2016 - 2027

Chapter 9 Regional Business Analysis

  • 9.1 Molecular diagnostics market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America, SWOT Analysis
    • 9.2.2 U.S.
    • 9.2.3 Canada
  • 9.3 Europe
    • 9.3.1 Europe, SWOT Analysis
    • 9.3.2 U.K.
    • 9.3.3 Germany
    • 9.3.4 France
    • 9.3.5 Italy
    • 9.3.6 Spain
    • 9.3.7 Belgium
    • 9.3.8 Switzerland
    • 9.3.9 Netherlands
    • 9.3.10 Poland
    • 9.3.11 Austria
    • 9.3.12 Greece
    • 9.3.13 Sweden
    • 9.3.14 Turkey
    • 9.3.15 Finland
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific, SWOT Analysis
    • 9.4.2 India
    • 9.4.3 China
    • 9.4.4 Japan
    • 9.4.5 Sri Lanka
    • 9.4.6 Malaysia
    • 9.4.7 Australia
    • 9.4.8 New Zealand
    • 9.4.9 Thailand
    • 9.4.10 Vietnam
    • 9.4.11 Singapore
  • 9.5 Latin America
    • 9.5.1 Latin America, SWOT Analysis
    • 9.5.2 Mexico
    • 9.5.3 Brazil
    • 9.5.4 Chile
    • 9.5.5 Peru
    • 9.5.6 Colombia
    • 9.5.7 Argentina
  • 9.6 MEA
    • 9.6.1 Middle East & Africa, SWOT Analysis
    • 9.6.2 South Africa
    • 9.6.3 Saudi Arabia
    • 9.6.4 Jordan
    • 9.6.5 UAE
    • 9.6.6 Qatar
    • 9.6.7 Nigeria
    • 9.6.8 Egypt

Chapter 10 Company Profiles

  • 10.1 Market Participation Categorization
  • 10.2 Company Profiles
    • 10.2.1 Abbott
      • 10.2.1.1 Company overview
      • 10.2.1.2 Alere, Inc.
      • 10.2.1.3 Financial performance
      • 10.2.1.4 Product benchmarking
      • 10.2.1.5 Strategic initiatives
    • 10.2.2 Becton, Dickinson and Company
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.3 bioMerieux SA
      • 10.2.3.1 Company overview
      • 10.2.3.2 Financial performance
      • 10.2.3.3 Product benchmarking
      • 10.2.3.4 Strategic initiatives
    • 10.2.4 Bio-Rad Laboratories, Inc.
      • 10.2.4.1 Company overview
      • 10.2.4.2 Financial performance
      • 10.2.4.3 Product benchmarking
      • 10.2.4.4 Strategic initiatives
    • 10.2.5 Agilent Technologies, Inc.
      • 10.2.5.1 Company overview
      • 10.2.5.2 Financial performance
      • 10.2.5.3 Product benchmarking
      • 10.2.5.4 Strategic initiatives
    • 10.2.6 Danaher Corporation
      • 10.2.6.1 Company overview
      • 10.2.6.2 Cepheid
      • 10.2.6.3 Beckman Coulter
      • 10.2.6.4 Leica Biosystems
      • 10.2.6.5 Financial performance
      • 10.2.6.6 Product benchmarking
      • 10.2.6.7 Strategic initiatives
      • 10.2.6.8 Strategic initiatives of Cepheid
      • 10.2.6.9 Strategic initiatives of Beckman Coulter, Inc.
      • 10.2.6.10 Strategic initiatives of Leica Biosystems
    • 10.2.7 Hologic, Inc. (Gen Probe)
      • 10.2.7.1 Company overview
      • 10.2.7.2 Financial performance
      • 10.2.7.3 Product benchmarking
      • 10.2.7.4 Strategic initiatives
    • 10.2.8 Illumina, Inc.
      • 10.2.8.1 Company overview
      • 10.2.8.2 Financial performance
      • 10.2.8.3 Product benchmarking
      • 10.2.8.4 Strategic initiatives
    • 10.2.9 Johnson & Johnson Services, Inc.
      • 10.2.9.1 Company overview
      • 10.2.9.2 Financial performance
      • 10.2.9.3 Product benchmarking
      • 10.2.9.4 Strategic initiatives
    • 10.2.10 Novartis (Grifols)
      • 10.2.10.1 Company overview
      • 10.2.10.2 Financial performance
      • 10.2.10.3 Product benchmarking
      • 10.2.10.4 Strategic initiatives
    • 10.2.11 Qiagen
      • 10.2.11.1 Company overview
      • 10.2.11.2 Financial performance
      • 10.2.11.3 Product benchmarking
      • 10.2.11.4 Strategic initiatives
    • 10.2.12 F. Hoffmann-La Roche Ltd
      • 10.2.12.1 Company overview
      • 10.2.12.2 Financial performance
      • 10.2.12.3 Product benchmarking
      • 10.2.12.4 Strategic initiatives
    • 10.2.13 Siemens Healthcare Private Limited
      • 10.2.13.1 Company overview
      • 10.2.13.2 Financial performance
      • 10.2.13.3 Product benchmarking
      • 10.2.13.4 Strategic initiatives
    • 10.2.14 Sysmex Corporation
      • 10.2.14.1 Company overview
      • 10.2.14.2 Financial performance
      • 10.2.14.3 Product benchmarking
      • 10.2.14.4 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 5 North America PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 6 North America PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 7 North America ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 8 North America INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 11 North America sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 12 North America TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 13 North America others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 23 U.S. ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 28 U.S. TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 29 U.S. others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 37 Canada PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 38 Canada PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 39 Canada ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 40 Canada INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 43 Canada sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 44 Canada TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 45 Canada others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 53 Europe PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 54 Europe PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 55 Europe ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 56 Europe INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 59 Europe sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 60 Europe TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 61 Europe others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 69 U.K. PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 70 U.K. PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 71 U.K. ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 76 U.K. TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 77 U.K. others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 85 Germany PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 86 Germany PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 87 Germany ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 88 Germany INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 91 Germany sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 92 Germany TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 93 Germany others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 101 France PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 102 France PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 103 France ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 104 France INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 107 France sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 108 France TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 109 France others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 117 Spain PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 118 Spain PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 119 Spain ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 120 Spain INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 123 Spain sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 124 Spain TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 125 Spain others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 133 Italy PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 134 Italy PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 135 Italy ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 136 Italy INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 139 Italy sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 140 Italy TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 141 Italy others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 149 Belgium PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 150 Belgium PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 151 Belgium ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 156 Belgium TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 157 Belgium others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 197 Poland PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 198 Poland PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 199 Poland ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 200 Poland INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 203 Poland sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 204 Poland TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 205 Poland others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 213 Austria PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 214 Austria PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 215 Austria ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 216 Austria INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 219 Austria sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 220 Austria TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 221 Austria others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 229 Greece PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 230 Greece PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 231 Greece ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 232 Greece INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 235 Greece sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 236 Greece TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 237 Greece others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 245 Sweden PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 246 Sweden PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 247 Sweden ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 251 Sweden sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 252 Sweden TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 253 Sweden others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 254 Sweden molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 255 Sweden molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 256 Sweden molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 257 Sweden molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 258 Turkey molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 259 Turkey molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 260 Turkey molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 261 Turkey PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 262 Turkey PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 263 Turkey ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 264 Turkey INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 265 Turkey chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 266 Turkey mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 267 Turkey sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 268 Turkey TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 269 Turkey others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 270 Turkey molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 271 Turkey molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 272 Turkey molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 273 Turkey molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 274 Finland molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 275 Finland molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 276 Finland molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 277 Finland PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 278 Finland PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 279 Finland ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 280 Finland INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 281 Finland chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 282 Finland mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 283 Finland sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 284 Finland TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 285 Finland others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 286 Finland molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 287 Finland molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
  • TABLE 288 Finland molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
  • TABLE 289 Finland molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
  • TABLE 290 Asia Pacific molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 291 Asia Pacific molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
  • TABLE 292 Asia Pacific molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 293 Asia Pacific PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 294 Asia Pacific PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 295 Asia Pacific ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 296 Asia Pacific INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 297 Asia Pacific chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 298 Asia Pacific mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 299 Asia Pacific sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 300 Asia Pacific TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary, 2019
  • FIG. 4 Market trends & outlook
  • FIG. 5 Market segmentation & scope
  • FIG. 6 Market driver relevance analysis (Current & future impact)
  • FIG. 7 Global percentage of population, by age group, 2050 and 2000
  • FIG. 8 General trend shift from laboratory to Point of Care
  • FIG. 9 Market restraint relevance analysis (Current & future impact)
  • FIG. 10 Average selling price range of diagnostic tests, 2019
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Molecular diagnostics market product outlook key takeaways
  • FIG. 15 Molecular diagnostics market: Product movement analysis
  • FIG. 16 Global instruments market, 2016 - 2027 (USD Million)
  • FIG. 17 Global reagents market, 2016 - 2027 (USD Million)
  • FIG. 18 Global others market, 2016 - 2027 (USD Million)
  • FIG. 19 Molecular diagnostics market test location outlook: Key takeaways
  • FIG. 20 Molecular diagnostics market: Test location movement analysis
  • FIG. 21 Global PoC market, 2016 - 2027 (USD Million)
  • FIG. 22 Global self-test or OTC market, 2016 - 2027 (USD Million)
  • FIG. 23 Global central laboratories market, 2016 - 2027 (USD Million)
  • FIG. 24 Molecular diagnostics market technology outlook: Key takeaways
  • FIG. 25 Molecular diagnostics market: Technology movement analysis
  • FIG. 26 Global PCR market, 2016 - 2027 (USD Million)
  • FIG. 27 Global multiplex PCR market, 2016 - 2027 (USD Million)
  • FIG. 28 Global other PCR market, 2016 - 2027 (USD Million)
  • FIG. 29 Global in situ hybridization market, 2016 - 2027 (USD Million)
  • FIG. 30 Global INAAT market, 2016 - 2027 (USD Million)
  • FIG. 31 Global chips and microarrays market, 2016 - 2027 (USD Million)
  • FIG. 32 Global mass spectrometry market, 2016 - 2027 (USD Million)
  • FIG. 33 Global sequencing market, 2016 - 2027 (USD Million)
  • FIG. 34 Global TMA market, 2016 - 2027 (USD Million)
  • FIG. 35 Global other market, 2016 - 2027 (USD Million)
  • FIG. 36 Molecular diagnostics market application outlook: Key takeaways
  • FIG. 37 Molecular diagnostics market: Application movement analysis
  • FIG. 38 Global oncology market, 2016 - 2027 (USD Million)
  • FIG. 39 Global breast cancer market, 2016 - 2027 (USD Million)
  • FIG. 40 Global prostate cancer market, 2016 - 2027 (USD Million)
  • FIG. 41 Global colorectal cancer market, 2016 - 2027 (USD Million)
  • FIG. 42 Global cervical cancer market, 2016 - 2027 (USD Million)
  • FIG. 43 Global kidney cancer market, 2016 - 2027 (USD Million)
  • FIG. 44 Global Liver Cancer market, 2016 - 2027 (USD Million)
  • FIG. 45 Global blood cancer market, 2016 - 2027 (USD Million)
  • FIG. 46 Global lung cancer market, 2016 - 2027 (USD Million)
  • FIG. 47 Global other market, 2016 - 2027(USD Million)
  • FIG. 48 Global pharmacogenomics market, 2016 - 2027(USD Million)
  • FIG. 49 Global infectious disease market, 2016 - 2027(USD Million)
  • FIG. 50 Global MRSA market, 2016 - 2027(USD Million)
  • FIG. 51 Global clostridium difficile market, 2016 - 2027(USD Million)
  • FIG. 52 Global vancomycin-resistant enterococci market, 2016 - 2027(USD Million)
  • FIG. 53 Global carbapenem-resistant bacteria market, 2016 - 2027(USD Million)
  • FIG. 54 Global flu market, 2016 - 2027 (USD Million)
  • FIG. 55 Global RSV market, 2016 - 2027(USD Million)
  • FIG. 56 Global candida market, 2016 - 2027(USD Million)
  • FIG. 57 Global tuberculosis and drug-resistant TB market, 2016 - 2027 (USD Million)
  • FIG. 58 Global meningitis market, 2016 - 2027 (USD Million)
  • FIG. 59 Global gastro-intestinal panel market, 2016 - 2027 (USD Million)
  • FIG. 60 Global chlamydia market, 2016 - 2027 (USD Million)
  • FIG. 61 Global gonorrhea market, 2016 - 2027 (USD Million)
  • FIG. 62 Global HIV market, 2016 - 2027 (USD Million)
  • FIG. 63 Global hepatitis C market, 2016 - 2027 (USD Million)
  • FIG. 64 Global Hepatitis B market, 2016 - 2027 (USD Million)
  • FIG. 65 Global market for others, 2016 - 2027 (USD Million)
  • FIG. 66 Global genetic testing market, 2016 - 2027 (USD Million)
  • FIG. 67 Global newborn screening market, 2016 - 2027 (USD Million)
  • FIG. 68 Global predictive and presymptomatic testing market, 2016 - 2027 (USD Million)
  • FIG. 69 Global other market, 2016 - 2027 (USD Million)
  • FIG. 70 Global neurological disease market, 2016 - 2027 (USD Million)
  • FIG. 71 Global cardiovascular disease market, 2016 - 2027 (USD Million)
  • FIG. 72 Global microbiology market, 2016 - 2027 (USD Million)
  • FIG. 73 Global other technology market, 2016 - 2027 (USD Million)
  • FIG. 74 Regional market place: Key takeaways, 2019
  • FIG. 75 Regional outlook, 2019 & 2027
  • FIG. 76 North America molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 77 U.S. molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 78 Canada molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 79 Europe molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 80 U.K. molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 81 Germany molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 82 France molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 83 Spain molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 84 Italy molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 85 Belgium molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 86 Switzerland molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 87 Netherlands molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 88 Poland molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 89 Austria molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 90 Greece molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 91 Sweden molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 92 Turkey molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 93 Finland molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 94 Asia Pacific molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 95 Japan molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 96 China molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 97 India molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 98 Australia molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 99 New Zealand molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 100 Sri Lanka molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 101 Malaysia molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 102 Thailand molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 103 Vietnam molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 104 Singapore molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 105 Latin America molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 106 Brazil molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 107 Mexico molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 108 Colombia molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 109 Chile molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 110 Peru molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 111 Argentina molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 112 MEA molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 113 South Africa molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 114 Saudi Arabia molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 115 Jordan molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 116 UAE molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 117 Qatar molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 118 Nigeria molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 119 Egypt molecular diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 120 Strategy framework
  • FIG. 121 Participant categorization
  • FIG. 122 North America molecular diagnostics market, 2016 - 2027 (USD Million)